
Dr. Jason Hawkes explores the unique clinical manifestations of atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis, while highlighting the shared role of type 2 inflammation across these distinct diseases.
Dr. Naiem Issa examines the shared and distinct features of atopic dermatitis and prurigo nodularis, highlighting the role of type 2 inflammation in both diseases.
Dr. Naiem Issa debunks common misconceptions in prurigo nodularis with key clinical insights.

Dr. Jason Hawkes provides key pathophysiologic insights and debunks common misconceptions surrounding atopic dermatitis.
Dr. Diego Dasliva untangles popular misconceptions surrounding chronic spontaneous urticaria.

Dr. Lakshi Aldredge sets the record straight regarding common misconceptions about prurigo nodularis.
Dr. Ahuva Cices provides key pathophysiologic insights and dispels common misconceptions surrounding atopic dermatitis.

In this webinar, Drs. David Cotter, Daniel Butler, and Walter Liszewski share key clinical insights, highlighting the central role of type 2 inflammation across atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria while addressing prevalent scientific misconceptions.
Dr. David Cotter discusses how atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis present uniquely in practice—and how type 2 inflammation links these distinct disease states.
Dr. Yu and Dr. Wine Lee discuss the clinical presentation and burden of atopic dermatitis, the role of type 2 inflammation in the development of atopic comorbidities, and the importance of early intervention in potentially preventing cumulative life course impairment in AD at PeDRA 2025.

Dr. Daniel Butler tackles prevalent misconceptions surrounding prurigo nodularis.

Dr. Walter Liszewski sheds light on chronic spontaneous urticaria by untangling widespread misconceptions.